PDL BioPharma Inc. (NASDAQ: PDLI) dropped 5% on Monday to post a new 52-week low of $6.52 against a 52-week high of $10.26. The stock closed at $6.87 on Friday night. Volume was about equal to the daily average of around 4 million shares. The company had no specific news today, but is scheduled to report first quarter results on Wednesday.
3D Systems Corp. (NYSE: DDD) dropped 1.6% on Monday to add to post a new 52-week low of $24.51 after closing at $24.92 on Friday. The stock’s 52-week high is $69.56. Share volume was about 30% below the daily average of around 2.8 million shares traded. The company announced a distribution deal this morning, but the stock price fades as investors await first quarter results, also due Wednesday from the 3D printer maker.
Zulily Inc. (NASDAQ: ZU) also posted a second consecutive 52-week low on Monday. Shares dropped 2.2% to $11.88 from Friday’s closing price of $12.15. The stock’s 52-week high is $50.39. Volume was about 10% above the daily average of around 2.6 million shares. The company had no news today.
Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) dropped about 10% on Monday to post a new 52-week low of $9.80 after closing at $10.90 on Friday. The stock’s 52-week high is $18.48. Share volume was more than double the daily average of around 1.6 million shares traded. The company reported a first quarter loss this morning.
ALSO READ: 15 Companies Losing the Most Money
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
